:

Homeland Security

Tests Show HGS’ ABthrax Improves Survival Rates

DDN

Wednesday, January 9th, 2008

SHARE:

The results of two animal studies show that the drug ABthrax improves survival rates in by up to 64 percent when administered after animals were symptomatic for anthrax disease as a result of inhalation exposure to massively lethal doses of anthrax spores, according to Human Genome Sciences, Inc. [HGSI], the developer of ABthrax. HGS says the results demonstrated a survival benefit in two animal species, which meets the requirement for establishing efficacy of new drugs used to counter bio-terrorism. "These…

Senators Push Navy Against Single Destroyer Request In FY ’27

The chairman of the Senate Armed Services Committee (SASC) and the two senators from Maine last week pushed back on Navy officials for only requesting one Arleigh Burke-class destroyer (DDG-51) […]

Navy Looks To Eventually Assemble Battleship At HII Newport News; Faces More Dem Opposition

The Navy told lawmakers this week it found a dry dock at HII’s [HII] Newport News Shipbuilding shipyard it thinks can use for final assembly of the new Trump-class battleship […]

Navy Leaders Downplay Looking At Foreign Navy Shipbuilding Amid Lawmaker Objections

The Navy’s top leaders this week seemed to downplay and back down on the service potentially using foreign shipyards to build U.S. Navy ships or buying foreign designed warships overseas […]

Army

Senate Defense Appropriators See ‘Risk’ With Army’s Reconciliation Plan To Fund Munitions Increase

The Senate’s top defense appropriators cited concern this week with the Army’s request to fund the majority of its large increase to munitions procurement in fiscal year 2027 through the […]